Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/1
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai)
Description: Subject matter under Class 424 definition which contains a designated organic active ingredient, e.g., coal tar, coal tar oil, etc.










Sub-classes under this class:

Class Number Class Name Patents
514/ Heterocyclic carbon cpmpounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 0
514/149 Azoxy doai 54
514/150 Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai 288
514/152 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai 329
514/155 Para-n-benzene - sulfoxy-n containing doai, and said benzene ring is not part of a polycyclo ring system 77
514/159 Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative doai 380
514/167 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai 707
514/169 Cyclopentanohydrophenanthrene ring system doai 611
514/183 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 2,142
514/2 Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai 7,690
514/22 Lignin or derivative doai 51
514/23 Carbohydrate (i.e., saccharide radical containing) doai 1,811
514/476 N-c(=x)x containing (x is chalcogen) doai 179
514/492 Heavy metal containing doai 681
514/506 Ester doai 329
514/553 Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai 295
514/579 Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai 301
514/63 Silicon containing doai 1,033
514/64 Boron containing doai 255
514/65 Pyrethrum plant derived material or plant derived rotenone compound containing doai 96
514/675 Ketone doai 216
514/693 Aldehyde doai 172
514/706 Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.) 247
514/714 Peroxide doai 141
514/715 Ether doai 140
514/724 C-o-group (e.g., alcohol, alcoholate, etc.) doai 587
514/740 Nitrogen containing compound doai 149
514/743 Halogenated hydrocarbon doai 80
514/75 Phosphorus containing other than solely as part of an inorganic ion in an addition salt doai 320
514/762 Hydrocarbon doai 190


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number Title Of Patent Date Issued
6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof Feb. 24, 2004
6696064 Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy Feb. 24, 2004
6693135 Prostaglandin compositions and methods of treatment for male erectile dysfunction Feb. 17, 2004
6689741 Biocompatible polymers, process for their preparation and compositions containing them Feb. 10, 2004
6682715 Nucleosides for imaging and treatment applications Jan. 27, 2004
6683045 Nucleosides for imaging and treatment applications Jan. 27, 2004
6680068 Drug delivery formulations and targeting Jan. 20, 2004
6676950 Neurokinin receptor antagonists and methods of use thereof for inhibiting HIV infection Jan. 13, 2004
6677298 Regulators of PPAR.delta. (.beta.) and their use in the treatment of obesity and insulin resistance Jan. 13, 2004
6677299 Method to increase cerebral blood flow in amyloid angiopathy Jan. 13, 2004
6677314 Nucleosides for imaging and treatment applications Jan. 13, 2004
6677315 Nucleosides for imaging and treatment applications Jan. 13, 2004
6677317 Disaccharide derivatives for treating hyperglycaemia Jan. 13, 2004
6673777 Guanylhydrazones useful for treating diseases associated with T cell activation Jan. 6, 2004
6673558 Drug compositions to prevent desensitization of cellular receptors Jan. 6, 2004
6670332 Complex cationic lipids having quarternary nitrogens therein Dec. 30, 2003
6660268 Proteasome regulation of NF-KB activity Dec. 9, 2003
6660720 Targeted oligonucleotide conjugates Dec. 9, 2003
6652885 Purification and stabilization of peptide and protein pharmaceutical agents Nov. 25, 2003
6653278 Selenium-containing pro-drugs for cancer therapy Nov. 25, 2003
6641811 Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression Nov. 4, 2003
6638915 Anti-viral composition Oct. 28, 2003
6638913 Concentrated injection and infusion solution for intravenous administration Oct. 28, 2003
6632789 Methods for modulating T cell responses by manipulating intracellular signal transduction Oct. 14, 2003
6624138 Drug-loaded biological material chemically treated with genipin Sep. 23, 2003
6617305 Stable aqueous dispersion of nutrients Sep. 9, 2003
6605299 Releasable linkage and compositions containing same Aug. 12, 2003
6596262 Modulated release particles for aerosol delivery Jul. 22, 2003
6593301 Use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds Jul. 15, 2003
6579525 Pharmaceutical compositions comprising erythropoietin for treatment of cancer Jun. 17, 2003
6576242 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis Jun. 10, 2003
6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor Jun. 10, 2003
6572858 Uses for anti-malarial therapeutic agents Jun. 3, 2003
6566086 Diagnostic kit for detecting creatine levels May. 20, 2003
6566324 Preventing airway mucus production by administration of EGF-R antagonists May. 20, 2003
6562347 Chemokine-tumor antigen fusion proteins as cancer vaccines May. 13, 2003
6551989 Preventing airway mucus production by administration of EGF-R antagonists Apr. 22, 2003
6552007 Use of somatostatin analogs for the delivery of anti-tumor drugs to tumor cells Apr. 22, 2003
6551578 Modulated release particles for aerosol delivery Apr. 22, 2003
6544959 High affinity nucleic acid ligands to lectins Apr. 8, 2003
6541005 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis Apr. 1, 2003
6537964 Reversal of multidrug resistance in human colon carcinoma cells Mar. 25, 2003
6528259 Methods for detecting human methylenetetrahydrofolate reductase allelic variants Mar. 4, 2003
6525031 Targeted Oligonucleotide conjugates Feb. 25, 2003
6524571 Methioninase gene therapy for tumor treatment Feb. 25, 2003
6509153 Genetic markers of toxicity preparation and uses Jan. 21, 2003
6500808 Anti-viral composition Dec. 31, 2002
6498145 Use of purified SDG as a hypotensive (vasodilator) agent Dec. 24, 2002
6495523 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration Dec. 17, 2002
6479231 Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1 (hOAT1) Nov. 12, 2002

1 2 3 4 5 6 7 8 9 10 11 12 13 14










 
 
  Recently Added Patents
High-speed comparator with asymmetric frequency response
Printer
Flexible lighting devices
Scalable packet processing systems and methods
Modulation of HSP47 expression
Biaxially oriented hydrolysis-stable polyester film comprising epoxidized fatty acid derivatives and a chain extender, and process for production thereof and use thereof
Mobile communication device monitoring systems and methods
  Randomly Featured Patents
Heuchera plant named `Caroline`
Air directing device for a power saw
Swinging seat with spring suspension
Rotatable shrouded valve for improving a scavenging of 2-stroke engine
System and method for identifying defects in a composite structure
Laryngoscope and method
Method for treating bladder cancer with a keyhole limpet hemocyanin composition having enhanced anti-tumor activity
Apparatus for fluid-bed catalytic reactions
Combination of photosensitive elements suited for use in radiography
Video game control grip